BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35726498)

  • 1. Human Milk Antibody Response After Combining Two Different COVID-19 Vaccines: Mix-and-Match.
    Mulleners SJ; Juncker HG; van Gils MJ; van Goudoever JB; van Keulen BJ
    J Hum Lact; 2022 Aug; 38(3):401-406. PubMed ID: 35726498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study.
    Selma-Royo M; Bäuerl C; Mena-Tudela D; Aguilar-Camprubí L; Pérez-Cano FJ; Parra-Llorca A; Lerin C; Martínez-Costa C; Collado MC
    Genome Med; 2022 Apr; 14(1):42. PubMed ID: 35449030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the human milk antibody response after vaccination with four COVID-19 vaccines: A prospective, longitudinal cohort study in the Netherlands.
    Juncker HG; Mulleners SJ; Ruhé EJM; Coenen ERM; Bakker S; van Doesburg M; Harinck JE; Rood RD; Bouhuijs JH; Oomen M; de Groot PCJM; Pajkrt PD; Korosi A; van Goudoever PJB; van Gils MJ; van Keulen BJ
    EClinicalMedicine; 2022 May; 47():101393. PubMed ID: 35465077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune response after different SARS-CoV-2 vaccination regimens.
    Rose R; Neumann F; Grobe O; Lorentz T; Fickenscher H; Krumbholz A
    BMC Med; 2022 Jan; 20(1):31. PubMed ID: 35057798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination.
    Juncker HG; Mulleners SJ; van Gils MJ; de Groot CJM; Pajkrt D; Korosi A; van Goudoever JB; van Keulen BJ
    J Hum Lact; 2021 Aug; 37(3):477-484. PubMed ID: 34176363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of SARS-CoV-2-Specific Antibodies in Human Breast Milk and Their Neutralizing Capacity after COVID-19 Vaccination: A Systematic Review.
    Nicolaidou V; Georgiou R; Christofidou M; Felekkis K; Pieri M; Papaneophytou C
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Profiles of SARS-CoV-2 Spike-Specific Human Milk Antibodies Elicited by mRNA- and Adenovirus-Based COVID-19 Vaccines.
    Yang X; Fox A; DeCarlo C; Norris C; Griffin S; Wedekind S; Flanagan JM; Shenker N; Powell RL
    Breastfeed Med; 2022 Aug; 17(8):638-646. PubMed ID: 35675683
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant Dyads.
    Golan Y; Prahl M; Cassidy AG; Gay C; Wu AHB; Jigmeddagva U; Lin CY; Gonzalez VJ; Basilio E; Chidboy MA; Warrier L; Buarpung S; Li L; Murtha AP; Asiodu IV; Ahituv N; Flaherman VJ; Gaw SL
    Front Immunol; 2021; 12():777103. PubMed ID: 34804068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of SARS-CoV-2 specific IgG and IgA antibodies in serum and milk with different SARS-COV-2 vaccines in lactating women.
    Lechosa-Muñiz C; Paz-Zulueta M; Irure-Ventura J; Mendez-Legaza JM; Cuesta González R; Gómez-Acebo I; López-Hoyos M; Llorca J; Cabero-Pérez MJ
    Int Breastfeed J; 2023 Jan; 18(1):3. PubMed ID: 36627706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of SARS-CoV-2-Specific IgA in the Human Milk of COVID-19 Vaccinated Lactating Health Care Workers.
    Valcarce V; Stafford LS; Neu J; Cacho N; Parker L; Mueller M; Burchfield DJ; Li N; Larkin J
    Breastfeed Med; 2021 Dec; 16(12):1004-1009. PubMed ID: 34427487
    [No Abstract]   [Full Text] [Related]  

  • 11. SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participants.
    Longueira Y; Ojeda DS; Battistelli RBA; Sanchez L; Oviedo Rouco S; Albano D; Guevara E; Valls V; Pando MA; Gamarnik AV
    Front Immunol; 2022; 13():909995. PubMed ID: 36263055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
    Costa Clemens SA; Weckx L; Clemens R; Almeida Mendes AV; Ramos Souza A; Silveira MBV; da Guarda SNF; de Nobrega MM; de Moraes Pinto MI; Gonzalez IGS; Salvador N; Franco MM; de Avila Mendonça RN; Queiroz Oliveira IS; de Freitas Souza BS; Fraga M; Aley P; Bibi S; Cantrell L; Dejnirattisai W; Liu X; Mongkolsapaya J; Supasa P; Screaton GR; Lambe T; Voysey M; Pollard AJ;
    Lancet; 2022 Feb; 399(10324):521-529. PubMed ID: 35074136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial.
    Madhavan M; Ritchie AJ; Aboagye J; Jenkin D; Provstgaad-Morys S; Tarbet I; Woods D; Davies S; Baker M; Platt A; Flaxman A; Smith H; Belij-Rammerstorfer S; Wilkins D; Kelly EJ; Villafana T; Green JA; Poulton I; Lambe T; Hill AVS; Ewer KJ; Douglas AD
    EBioMedicine; 2022 Nov; 85():104298. PubMed ID: 36229342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 mRNA vaccine and antibody response in lactating women: a prospective cohort study.
    Charepe N; Gonçalves J; Juliano AM; Lopes DG; Canhão H; Soares H; Serrano EF
    BMC Pregnancy Childbirth; 2021 Sep; 21(1):632. PubMed ID: 34535094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained and Boosted Antibody Responses in Breast Milk After Maternal SARS-CoV-2 Vaccination.
    Ware J; McElhinney K; Latham T; Lane A; Dienger-Stambaugh K; Hildeman D; Spearman P; Ware RE
    Breastfeed Med; 2023 Aug; 18(8):612-620. PubMed ID: 37615566
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of Human Milk Antibody Induction, Persistence, and Neutralizing Capacity With SARS-CoV-2 Infection vs mRNA Vaccination.
    Young BE; Seppo AE; Diaz N; Rosen-Carole C; Nowak-Wegrzyn A; Cruz Vasquez JM; Ferri-Huerta R; Nguyen-Contant P; Fitzgerald T; Sangster MY; Topham DJ; Järvinen KM
    JAMA Pediatr; 2022 Feb; 176(2):159-168. PubMed ID: 34757387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
    Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
    Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in SARS-CoV-2 RBD-Specific IgA and IgG Antibodies in Human Milk From Lactating Women Following the COVID-19 Booster Vaccination.
    Henle AM
    J Hum Lact; 2023 Feb; 39(1):51-58. PubMed ID: 36398916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.